Apomorphine Subcutaneous and Insulin glargine and lixisenatide
Determining the interaction of Apomorphine Subcutaneous and Insulin glargine and lixisenatide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: apomorphine
Brand name: Apokyn, APO-Go, APO-Go Pen, Uprima
Synonyms: Apomorphine
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Apomorphine Subcutaneous-Insulin glargine and lixisenatide Subcutaneous
- Apomorphine Subcutaneous-Insulin glargine, recombinant Subcutaneous
- Apomorphine Subcutaneous-Insulin glulisine
- Apomorphine Subcutaneous-Insulin Glulisine (Cartridges and Pens)
- Apomorphine Subcutaneous-Insulin Glulisine (Vials)
- Apomorphine Subcutaneous-Insulin glulisine Subcutaneous
- Insulin glargine and lixisenatide-Apra
- Insulin glargine and lixisenatide-Apraclonidine
- Insulin glargine and lixisenatide-Apraclonidine Hydrochloride
- Insulin glargine and lixisenatide-Apraclonidine ophthalmic
- Insulin glargine and lixisenatide-Apremilast
- Insulin glargine and lixisenatide-Aprepitant